Harnessing Bacterial Agents to Modulate the Tumor Microenvironment and Enhance Cancer Immunotherapy is a research paper published in Cancers (2024). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Health
Grant: R01CA221867
National Institute of Health
Grant: R01CA273002
National Institute of Health
Grant: R01CA282254
National Institute of Health
Grant: 1R21AI167793
NIGMS NIH HHS
Grant: T32 GM135748
NIAID NIH HHS
Grant: R21 AI167793
NIH HHS
Grant: R01CA221867, R01CA273002
National Institutes of Health
Grant: 5R01CA273002-02
Combating melanoma with an attenuated bacterial therapeutic
National Institutes of Health
Grant: 1R21AI167793-01A1
Combating chronic neuroinflammatory disorders by targeting NAC1
National Institutes of Health
Grant: 1R01CA282254-01A1
Integrative Targeted Therapy for Melanoma
National Institutes of Health
Grant: 5R01CA221867-03
Nucleus Accumbens-Associated Protein-1 in Melanoma Immunotherapy
FWCI
7.00
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals